Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2002-
    • Subject Terms:
    • Abstract:
      Competing Interests: Declarations. Ethical approval and consent to participate: This study involving human participants was reviewed and approved by the Ethics Review Committee of Peking University. Written informed consent was obtained from all participants prior to their inclusion in the study. Competing interests: The authors declare no competing interests.
      Background: The triglyceride-glucose (TyG) index, TyG-body mass index (TyG-BMI), TyG-waist circumference (TyG-WC), TyG-waist-to-height ratio (TyG-WHtR), and estimated glucose disposal rate (eGDR) serve as surrogate markers of insulin resistance (IR) and are associated with cardiometabolic diseases (CMDs). However, the joint effects of TyG-related indices and eGDR on cardiometabolic multimorbidity (CMM) risk remains unclear. This study aims to assess both separate and combined effects of TyG-related indices and eGDR on CMM.
      Methods: The data of this study derived from the China Health and Retirement Longitudinal Study (CHARLS). TyG-related indices and eGDR were dichotomized at their median levels for participant categorization. Univariate and multivariate Cox regression and restricted cubic splines (RCS) analyzed effects of TyG-related indices and eGDR on CMM, while receiver operating characteristic (ROC) curves, net reclassification improvement (NRI) and integrated discrimination improvement (IDI) assessed their predictive performance. Meanwhile, the mutual mediating effects and interaction effects were further assessed.
      Results: This study included 5,854 participants (male: 47.5%, median age: 57.0 years). Compared to low TyG-related indices plus high eGDR, High TyG-related indices plus low eGDR had elevated CMM risks: TyG (HR 3.59, 95% CI 2.28-5.65), TyG-BMI (HR 3.40, 95% CI 2.30-5.02), TyG-WC (HR 3.85, 95% CI 2.58-5.75), and TyG-WHtR (HR 3.62, 95% CI 2.43-5.39). Furthermore, the addition of TyG-related indices combined with eGDR to the basic model significantly improved CMM risk prediction: TyG (AUC 0.713, NRI 0.363, IDI 0.008, all p < 0.05); TyG-BMI (AUC 0.729, NRI 0.479, IDI 0.011, all p < 0.05); TyG-WC (AUC 0.716, NRI 0.419, IDI 0.010, all p < 0.05); and TyG-WHtR (AUC 0.717, NRI 0.379, IDI 0.010, all p < 0.05). Moreover, the mediation analysis demonstrated that eGDR significantly mediated all TyG-related indices' associations with CMM, with only obesity-related TyG indices mediating the association between eGDR and CMM. Notably, no significant additive or multiplicative interaction was observed between any TyG-related indices and eGDR for CMM risk.
      Conclusions: High TyG-related indices and low eGDR were independently and jointly associated with higher CMM risk. Joint application of TyG-related indices and eGDR could improve early identification and prevention of CMM.
      (© 2025. The Author(s).)
    • References:
      Eur Heart J. 2023 Feb 14;44(7):573-582. (PMID: 36577740)
      BMJ Open. 2019 Mar 3;9(3):e024476. (PMID: 30833320)
      Diabetes Care. 2009 Jul;32(7):1302-7. (PMID: 19389821)
      Front Endocrinol (Lausanne). 2025 Apr 01;16:1511319. (PMID: 40235659)
      Endocr Rev. 2019 Dec 1;40(6):1447-1467. (PMID: 31050706)
      Eur J Intern Med. 2023 Nov;117:50-51. (PMID: 37709557)
      Front Endocrinol (Lausanne). 2023 Jul 18;14:1215521. (PMID: 37534213)
      Cardiovasc Diabetol. 2025 Jan 29;24(1):45. (PMID: 39881304)
      J Am Heart Assoc. 2022 Feb;11(3):e023667. (PMID: 35060389)
      JAMA. 2015 Jul 7;314(1):52-60. (PMID: 26151266)
      Sci Rep. 2024 Aug 17;14(1):19054. (PMID: 39154111)
      JAMA Netw Open. 2019 Dec 2;2(12):e1916591. (PMID: 31800066)
      Trends Cell Biol. 2001 Nov;11(11):437-41. (PMID: 11684411)
      Arch Endocrinol Metab. 2025 Apr 15;69(2):e230493. (PMID: 40232167)
      Nat Rev Dis Primers. 2022 Jul 14;8(1):48. (PMID: 35835758)
      Sci Rep. 2025 Jan 19;15(1):2443. (PMID: 39828736)
      N Engl J Med. 2014 Dec 4;371(23):2236. (PMID: 25470707)
      ESC Heart Fail. 2024 Dec;11(6):3833-3841. (PMID: 39016168)
      Diabetes Metab Syndr. 2018 Sep;12(5):661-666. (PMID: 29678607)
      J Diabetes. 2024 May;16(5):e13482. (PMID: 38225901)
      Diabetes Metab Res Rev. 2024 Jan;40(1):e3764. (PMID: 38287717)
      Front Endocrinol (Lausanne). 2020 Jan 14;10:861. (PMID: 31993018)
      Cardiovasc Diabetol. 2025 Feb 28;24(1):98. (PMID: 40022122)
      Hypertension. 2021 Nov;78(5):1197-1205. (PMID: 34601960)
      J Am Heart Assoc. 2025 May 6;14(9):e039152. (PMID: 40281653)
      World J Cardiol. 2022 Jun 26;14(6):363-371. (PMID: 35979178)
      Diabetes Res Clin Pract. 2024 Nov;217:111894. (PMID: 39414087)
      J Hypertens. 2025 Sep 1;43(9):1554-1560. (PMID: 40586243)
      Metabolism. 2021 Jun;119:154766. (PMID: 33766485)
      Sci Rep. 2025 Jun 4;15(1):19571. (PMID: 40467641)
      Endocrinol Diabetes Metab. 2025 Mar;8(2):e70037. (PMID: 40123264)
      Diabetol Metab Syndr. 2023 Nov 6;15(1):226. (PMID: 37926824)
      Cardiovasc Diabetol. 2025 Jan 29;24(1):47. (PMID: 39881352)
      Eur J Epidemiol. 2011 Jun;26(6):433-8. (PMID: 21344323)
      Am J Physiol. 1979 Sep;237(3):E214-23. (PMID: 382871)
      Cardiovasc Diabetol. 2024 Aug 22;23(1):307. (PMID: 39175051)
      Front Nutr. 2023 Dec 14;10:1304521. (PMID: 38156282)
      Nat Rev Endocrinol. 2025 Jul;21(7):413-426. (PMID: 40247011)
      Cardiovasc Diabetol. 2025 Jun 18;24(1):257. (PMID: 40533754)
      Int J Surg. 2024 Sep 01;110(9):5409-5416. (PMID: 38896856)
      J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):331-338. (PMID: 33619889)
      Ann Intern Med. 2009 May 5;150(9):604-12. (PMID: 19414839)
      J Clin Invest. 2006 Jul;116(7):1793-801. (PMID: 16823477)
      Diabetes. 2009 Apr;58(4):773-95. (PMID: 19336687)
      Obes Res Clin Pract. 2012 Oct-Dec;6(4):e263-346. (PMID: 24331592)
      Lipids Health Dis. 2025 Mar 07;24(1):87. (PMID: 40055792)
      Diabetes Obes Metab. 2025 Mar;27(3):1359-1368. (PMID: 39743837)
      J Endocr Soc. 2023 Jun 01;7(7):bvad069. (PMID: 37304203)
      BMC Endocr Disord. 2024 Nov 1;24(1):234. (PMID: 39487484)
      Cardiovasc Diabetol. 2020 Dec 10;19(1):210. (PMID: 33302952)
      Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15430-5. (PMID: 19706383)
      Aging Med (Milton). 2024 Dec 19;7(6):717-726. (PMID: 39777103)
      Diabetes Obes Metab. 2025 Sep;27(9):4763-4771. (PMID: 40485506)
      J Clin Endocrinol Metab. 2010 Jul;95(7):3347-51. (PMID: 20484475)
    • Grant Information:
      KY0120220041 NSFC Incubation Project of Guangdong Provincial People's Hospital; 2024A04J4157 Science and Technology Projects in Guangzhou; NO. 82300278 National Natural Science Foundation of China; No. Z022017016 Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention; 2022A1515012126 Guangdong Basic and Applied Basic Research Foundation; ESR-23-22118 AstraZeneca Externally Sponsored Research Project
    • Contributed Indexing:
      Keywords: CHARLS; Cardiometabolic multimorbidity; Estimated glucose disposal rate; Insulin resistance; Triglyceride glucose index
    • Accession Number:
      0 (Biomarkers)
      0 (Blood Glucose)
      0 (Triglycerides)
    • Publication Date:
      Date Created: 20251002 Date Completed: 20251003 Latest Revision: 20251114
    • Publication Date:
      20251115
    • Accession Number:
      PMC12492775
    • Accession Number:
      10.1186/s12933-025-02939-7
    • Accession Number:
      41039463